Lung disease encompasses acute, infectious processes and chronic, non-infectious
processes such as chronic obstructive pulmonary disease, asthma and lung cancer. People …

Introduction As of today, there is still a need to determine which COPD patients may benefit
from ICS therapy, whether ICSs are useful in COPD patients without chronic bronchitis, and …

Abstract LABA/ICS and LABA/LAMA/ICS combinations elicit beneficial effects in asthma.
Specific evidence concerning the impact of combining indacaterol acetate (IND) …

Introduction In patients with chronic obstructive pulmonary disease (COPD), treatment with
long-acting muscarinic antagonist (LAMA)/long-acting β 2-agonist (LABA) combination …

Introduction: The current recommendations of chronic obstructive pulmonary disease
(COPD) suggest to escalate from inhaled corticosteroid/long-acting β2-adrenoceptor agonist …

Objective: Combination therapy, including inhaled corticosteroids (ICS), is often prescribed
as initial treatment for Chronic Obstructive Pulmonary Disease (COPD) despite limited …

Introduction Long-acting muscarinic receptor antagonist (LAMA)/β2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …

Purpose: To evaluate the feasibility and success of a pharmacist-led, targeted inhaled
corticosteroid (ICS) de-escalation process in patients with chronic obstructive pulmonary …

慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease 简称COPD) 是一种慢性气道疾病,
主要表现为相应的呼吸道症状和不可逆的气流受限, 患病率高, 病死率高. 急性加重的频发会导致 …

Pharmacotherapeutic management of chronic obstructive pulmonary disease (COPD)
primarily involves the use of inhaled bronchodilators and inhaled corticosteroids (ICS) …